EcoR1 Capital »

Immunome shares owned by EcoR1 Capital

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by EcoR1 Capital from 13F filings

Historical chart of EcoR1 Capital investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by EcoR1 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by EcoR1 Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $42M 3.9M 10.70

More positions owned by EcoR1 Capital

Apellis Pharmaceuticals (APLS)
Mirati Therapeutics
Prothena Corp SHS (PRTA)
Arvinas Ord (ARVN)
Galapagos Nv Spon Adr (GLPG)
ACADIA Pharmaceuticals (ACAD)
Anaptysbio Inc Common (ANAB)
Zymeworks Del (ZYME)
Tango Therapeutics (TNGX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Argenx Se Sponsored Adr (ARGX)
Xencor (XNCR)
Kura Oncology (KURA)
Sarepta Therapeutics (SRPT)
Crinetics Pharmaceuticals In (CRNX)

View all positions for EcoR1 Capital

Top funds holding Immunome

EcoR1 Capital
Redmile Group
Vanguard Group
Henderson Group
Avidity Partners Management
T. Rowe Price Associates
Point72 Asset Management
Brown Advisory Holdings Incorporated
Alpine Partners VI
TD Asset Management
Prentice Capital Management
Jane Street
Laurion Capital Management
Barclays
HPM Partners

View all funds holding Immunome